These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9852885)

  • 1. Effect of implantable cardioverter-defibrillator implantation on surgical morbidity in the CABG Patch Trial. Surgical Investigators of the Coronary Artery Bypass Graft Patch Trial.
    Spotnitz HM; Herre JM; Raza ST; Hammon JW; Baker LD; Fitzgerald DM; Kron IL; Bigger JT
    Circulation; 1998 Nov; 98(19 Suppl):II77-80. PubMed ID: 9852885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical aspects of a randomized trial of defibrillator implantation during coronary artery bypass surgery. The CABG Patch Trial.
    Spotnitz HM; Herre JM; Baker LD; Fitzgerald DM; Kron IL; Bigger JT
    Circulation; 1996 Nov; 94(9 Suppl):II248-53. PubMed ID: 8901755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.
    Bigger JT
    N Engl J Med; 1997 Nov; 337(22):1569-75. PubMed ID: 9371853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump.
    Légaré JF; Buth KJ; King S; Wood J; Sullivan JA; Hancock Friesen C; Lee J; Stewart K; Hirsch GM
    Circulation; 2004 Feb; 109(7):887-92. PubMed ID: 14757693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
    J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery.
    Shahian DM; O'Brien SM; Filardo G; Ferraris VA; Haan CK; Rich JB; Normand SL; DeLong ER; Shewan CM; Dokholyan RS; Peterson ED; Edwards FH; Anderson RP;
    Ann Thorac Surg; 2009 Jul; 88(1 Suppl):S43-62. PubMed ID: 19559824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.
    Curtis AB; Cannom DS; Bigger JT; DiMarco JP; Estes NA; Steinman RC; Parides MK
    Am Heart J; 1997 Nov; 134(5 Pt 1):787-98. PubMed ID: 9398090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-pump versus on-pump myocardial revascularization in low-risk patients with one or two vessel disease: perioperative results in a multicenter randomized controlled trial.
    Gerola LR; Buffolo E; Jasbik W; Botelho B; Bosco J; Brasil LA; Branco JN
    Ann Thorac Surg; 2004 Feb; 77(2):569-73. PubMed ID: 14759439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive coronary revascularization in women: A safe approach for a high-risk group.
    Petro KR; Dullum MK; Garcia JM; Pfister AJ; Qazi AG; Boyce SW; Bafi AS; Stamou SC; Corso PJ
    Heart Surg Forum; 2000; 3(1):41-6. PubMed ID: 11064546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic low-energy shock wave therapy improves wound healing after vein harvesting for coronary artery bypass graft surgery: a prospective, randomized trial.
    Dumfarth J; Zimpfer D; Vögele-Kadletz M; Holfeld J; Sihorsch F; Schaden W; Czerny M; Aharinejad S; Wolner E; Grimm M
    Ann Thorac Surg; 2008 Dec; 86(6):1909-13. PubMed ID: 19022007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reoperative coronary artery bypass grafting with and without cardiopulmonary bypass: determinants of perioperative morbidity and mortality.
    D'Ancona G; Karamanoukian H; Ricci M; Salerno T; Lajos T; Bergsland J
    Heart Surg Forum; 2001; 4(2):152-8; dicussion 158-9. PubMed ID: 11550654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
    Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
    Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cardiopulmonary bypass in single vessel coronary revascularization: implications for MID-CABG.
    John R; Choudhri AF; Ting W; Smith CR; Rose EA; Oz MC
    Heart Surg Forum; 1998; 1(1):65-70. PubMed ID: 11276443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
    Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass grafting in patients with low ejection fraction.
    Topkara VK; Cheema FH; Kesavaramanujam S; Mercando ML; Cheema AF; Namerow PB; Argenziano M; Naka Y; Oz MC; Esrig BC
    Circulation; 2005 Aug; 112(9 Suppl):I344-50. PubMed ID: 16159844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
    White HD; Assmann SF; Sanborn TA; Jacobs AK; Webb JG; Sleeper LA; Wong CK; Stewart JT; Aylward PE; Wong SC; Hochman JS
    Circulation; 2005 Sep; 112(13):1992-2001. PubMed ID: 16186436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.